Identification and characterization of a TGF-β-independent SMAD4-NFATc1-STAT3 regulatory axis

Area of Science:

• Cellular Biology
• Molecular Oncology
• Signal Transduction

Background:

• SMAD4 is a key mediator of TGF-β signaling, crucial for cell proliferation, differentiation, and apoptosis.
• The non-canonical, TGF-β-independent functions of SMAD4 are not well understood, especially in disease contexts.
• Pancreatic ductal adenocarcinoma (PDAC) is a disease where SMAD4 alterations are common.

Purpose of the Study:

• To investigate the TGF-β-independent functions of SMAD4.
• To identify novel protein-protein interactions of SMAD4.
• To explore therapeutic vulnerabilities in SMAD4-deficient PDAC.

Main Methods:

• SMAD4-focused oncogenic protein-protein interaction mapping.
• Analysis of SMAD4-NFATc1 interaction in PDAC cells.
• Assessment of NFATc1 transcriptional activity and STAT3 expression.
• In vitro screening of STAT3 inhibitors against SMAD4-deficient PDAC cells.

Main Results:

• A novel, TGF-β-independent interaction between SMAD4 and NFATc1 was identified.
• SMAD4 sequesters NFATc1 in the cytoplasm, inhibiting its transcriptional activity.
• SMAD4 deficiency in PDAC leads to NFATc1 activation and STAT3 upregulation.
• STAT3 inhibitors show selective efficacy against SMAD4-deficient PDAC cells in vitro.

Conclusions:

• A previously uncharacterized SMAD4-NFATc1 regulatory complex exists.
• This complex plays a significant role in regulating NFATc1-driven transcription, including STAT3.
• These findings provide insights into SMAD4's non-canonical functions and suggest therapeutic strategies for SMAD4-deficient PDAC.